Roth Capital Maintains Buy on Cingulate, Raises Price Target to $17
Benzinga Newsdesk 1 year ago
NewsPrice TargetAnalyst Ratings
Roth Capital analyst Boobalan Pachaiyappan maintains Cingulate (NASDAQ:CING) with a Buy and raises the price target from $10 to $17.
Roth Capital analyst Boobalan Pachaiyappan maintains Cingulate (NASDAQ:CING) with a Buy and raises the price target from $10 to $17.